These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18938697)

  • 1. [Impact of cardiac rehabilitation programs on coronary risk profile].
    Ilarraza Lomelí H
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-48-55. PubMed ID: 18938697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term secondary prevention programs after cardiac rehabilitation for the reduction of future cardiovascular events: focus on regular physical activity.
    Scrutinio D; Temporelli PL; Passantino A; Giannuzzi P
    Future Cardiol; 2009 May; 5(3):297-314. PubMed ID: 19450055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac rehabilitation and exercise training in secondary coronary heart disease prevention.
    Lavie CJ; Milani RV
    Prog Cardiovasc Dis; 2011; 53(6):397-403. PubMed ID: 21545925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of risk factor modification through cardiac rehabilitation.
    Borrás IC; Cruz-Jiménez M; Nadal E; Middelhoff A; Rivera A
    Bol Asoc Med P R; 2008; 100(4):75-9. PubMed ID: 19400532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac rehabilitation.
    Stephens MB
    Am Fam Physician; 2009 Nov; 80(9):955-9; hand-out 960. PubMed ID: 19873962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: a scientific statement from the American Heart Association/American Association for Cardiovascular and Pulmonary Rehabilitation.
    King ML; Williams MA; Fletcher GF; Gordon NF; Gulanick M; King CN; Leon AS; Levine BD; Costa F; Wenger NK; ;
    Circulation; 2005 Nov; 112(21):3354-60. PubMed ID: 16301362
    [No Abstract]   [Full Text] [Related]  

  • 7. [National Registry of Cardiac Rehabilitation Programs in México].
    Ilarraza Lomelí H; Herrera Franco R; Lomelí Rivas A; Zavala Ramírez J; Martínez Ramírez L; Ramos Becerril FJ; Romo Escamilla RE; Pacheco Beltrán N; Alonso Sánchez J; Mendoza Díaz PM; Alvarez Cerro M; Cassaigne Guasco ME; Mayela Muñoz Gutiérrez LM
    Arch Cardiol Mex; 2009; 79(1):63-72. PubMed ID: 19545077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing psychosocial stress: a novel mechanism of improving survival from exercise training.
    Milani RV; Lavie CJ
    Am J Med; 2009 Oct; 122(10):931-8. PubMed ID: 19682669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation of statin treatment and all-cause mortality: a population-based cohort study.
    Shalev V; Chodick G; Silber H; Kokia E; Jan J; Heymann AD
    Arch Intern Med; 2009 Feb; 169(3):260-8. PubMed ID: 19204217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rehabilitation in ischemic cardiopathy. Is it fantasy or reality? Secondary prevention].
    Maroto Montero JM
    Rev Esp Cardiol; 1989 Jan; 42(1):49-64. PubMed ID: 2682822
    [No Abstract]   [Full Text] [Related]  

  • 11. Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC;
    J Clin Pharmacol; 2009 Aug; 49(8):947-56. PubMed ID: 19602720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project.
    Niu S; Zhao D; Zhu J; Liu J; Liu Q; Liu J; Wang W; Smith SC;
    Am Heart J; 2009 Apr; 157(4):709-15.e1. PubMed ID: 19332200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac rehabilitation programme for coronary heart disease patients: an integrative literature review.
    Eshah NF; Bond AE
    Int J Nurs Pract; 2009 Jun; 15(3):131-9. PubMed ID: 19531070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular risk profile and anti-hypertensive treatment].
    Olsen MH; Sehestedt T; Prescott E
    Ugeskr Laeger; 2009 Jun; 171(24):2008-11. PubMed ID: 19523363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical activity and cardiovascular disease.
    Benestad AM
    Scand J Soc Med Suppl; 1982; 29():179-83. PubMed ID: 6958040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized preventive care in cardiac rehabilitation: adapted from AACVPR Award of Excellence Lecture, Charleston, WVa, October, 2006.
    Ades PA
    J Cardiopulm Rehabil Prev; 2007; 27(3):130-4. PubMed ID: 17558192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention, second edition, 2004: executive summary.
    Stone JA; Arthur HM;
    Can J Cardiol; 2005 Oct; 21 Suppl D():3D-19D. PubMed ID: 16292364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heart 2001, a occupational preventive action in coronary risk patients].
    Cambou JP
    Soins; 2003 Apr; (674):51. PubMed ID: 12724999
    [No Abstract]   [Full Text] [Related]  

  • 20. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services.
    Thomas RJ; King M; Lui K; Oldridge N; Piña IL; Spertus J;
    Circulation; 2007 Oct; 116(14):1611-42. PubMed ID: 17885210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.